Agreement - Google Patents
Appendix A GlossaryAgreement
View HTML- Document ID
- 7822318717346785551
- Author
- Agreement A
External Links
Snippet
Appendix AGlossary Active pharmaceutical ingredient (API) Any substance or mixture of
substances that is part of a drug (medicinal) product, intended to furnish pharmacological activity
or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease, or to …
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q30/00—Commerce, e.g. shopping or e-commerce
- G06Q30/06—Buying, selling or leasing transactions
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/70—Chemoinformatics, i.e. data processing methods or systems for the retrieval, analysis, visualisation, or storage of physicochemical or structural data of chemical compounds
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/3456—Computer-assisted prescription or delivery of medication, e.g. prescription filling or compliance checking
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Vickers et al. | Field detection devices for screening the quality of medicines: a systematic review | |
| EP1938061B1 (en) | Rapid pharmaceutical identification and verification system | |
| Deisingh | Pharmaceutical counterfeiting | |
| Höllein et al. | Routine quality control of medicines in developing countries: analytical challenges, regulatory infrastructures and the prevalence of counterfeit medicines in Tanzania | |
| Bakker et al. | Current challenges in the detection and analysis of falsified medicines | |
| Fernandez et al. | Poor quality drugs: grand challenges in high throughput detection, countrywide sampling, and forensics in developing countries | |
| Tabernero et al. | A repeat random survey of the prevalence of falsified and substandard antimalarials in the Lao PDR: a change for the better | |
| Olsen et al. | Screening for counterfeit drugs using near-infrared spectroscopy | |
| Barras et al. | Nitrogen-14 nuclear quadrupole resonance spectroscopy: A promising analytical methodology for medicines authentication and counterfeit antimalarial analysis | |
| US9013686B2 (en) | Chemical and molecular identification and quantification system utilizing enhanced photoemission spectroscopy | |
| Kaur et al. | Antimalarial drug quality: methods to detect suspect drugs | |
| Tchounga et al. | Poor-quality medicines in Cameroon: a critical review | |
| Belugina et al. | Distinguishing paracetamol formulations: Comparison of potentiometric “Electronic Tongue” with established analytical techniques | |
| Lemos et al. | Forensic analysis of anabolic steroids tablets composition using attenuated total reflection Fourier transform infrared microspectroscopy (µATR‐FTIR) mapping | |
| Spálovská et al. | Comparison of genuine, generic and counterfeit Cialis tablets using vibrational spectroscopy and statistical methods | |
| Kammrath et al. | Detection and analysis of counterfeit drugs | |
| Arman et al. | Identifying falsified COVID-19 vaccines by analysing vaccine vial label and excipient profiles using MALDI-ToF mass spectrometry | |
| Agreement | Appendix A Glossary | |
| Bah-Traore | Quality assurance and safety issue of pharmaceutical products marketed in developing countries | |
| McCudden et al. | The Application of Magnetic Resonance to Testing Counterfeit, Falsified, and Substandard Medicines | |
| Trippe | Novel Approaches to the Detection of Substandard Medicines | |
| Nuhu | Recent analytical approaches to counterfeit drug detection | |
| Elbaramawi et al. | Various techniques for resolving overlapping ultraviolet spectra of combination pharmaceutical dosage forms containing hydroxychloroquine and paracetamol | |
| Liang | Structurally sophisticated or lamentably limited? Mechanisms to ensure safety of the medicine supply | |
| Elkins | Results from a survey of trends in seized counterfeit drugs |